USA Immuno-Oncology Drugs Market Report 2022
Report Highlights
The USA immuno-oncology drugs market grew from $11,282.3 million in 2016 to $31,002.4 million in 2021 at a compound annual growth rate (CAGR) of 22.4%. The USA immuno-oncology drugs market is expected to grow from $31,002.4 million in 2021 to $53,186.6 million in 2026 at a compound annual growth rate (CAGR) of 11.4%. The market is expected to grow to $84,279.7 million in 2031 at a compound annual growth rate (CAGR) of 9.6%.
USA Immuno-Oncology Drugs Market Report 2022 provides strategists, marketers and senior management with the critical information they need to assess the USA Immuno-Oncology Drugs market.
Reasons to Purchase
- Fully updated for 2022.
- Identify growth segments and opportunities.
- Facilitate decision making on the basis of historic and forecast data
- Develop strategies based on likely future developments.
- Gain a global perspective on the development of the market.
Description
USA Immuno-Oncology Drugs Market Report 2022 from the Business Research Company covers market characteristics, size and growth, trends and strategies for this market.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the Immuno-Oncology Drugs market revenues, covering both the historic growth of the market and forecasting the future.
- The trends and strategies section highlights the likely future developments in the Immuno-Oncology Drugs market and suggests approaches.
Scope
Markets Covered: Immuno-Oncology Drugs
Geographic scope: USA
Time series: Five years historic and forecast
Data: Market value in $ billions.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Table 1 : USA GDP Per Capita, 2015-2020, $
- Table 2 : USA, Population By Age Group, 2015-2025, Thousands
- Table 3 : USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2020, $ Billion
- Table 4 : USA Healthcare Services Market Size, 2016-2026, $ Billion
- Table 5 : North America Estimated Average Expenditure, Cancer Prevalence, 2019
- Table 6 : USA Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
- Table 7 : USA Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
- Table 8 : USA Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
- Table 9 : USA Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
- Table 10 : USA Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
- Table 11 : USA Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
- Table 12 : Immuno-Oncology Drugs - Market Data Sources
- Figure 1 : USA Immuno-Oncology Drugs Market, Historic, 2016 – 2021, $ Million
- Figure 2 : USA Immuno-Oncology Drugs Market, Forecast, 2021 – 2026, 2031F, $ Million
- Figure 3 : USA Immuno-Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
- Figure 4 : USA Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.
Similar Reports from TBRC (Publisher)
Asia Pacific Immuno-Oncology Drugs Market Report 2022
The Asia Pacific immuno-oncology drugs market grew from $6,553.6 million in 2016 to $14,779.7 million in 2021 at a compound annual growth rate (CAGR) of 17.7%. The Asia Pacific immuno-oncology drugs market is expected to grow from $14,779.7 million in 2021 to $24,154.8 million in 2026 at a compound annual growth rate (CAGR) of 10.3%. The market is expected to ...
North America Immuno-Oncology Drugs Market Report 2022
The North America immuno-oncology drugs market grew from $12,089.8 million in 2016 to $32,769.9 million in 2021 at a compound annual growth rate (CAGR) of 22.1%. The North America immuno-oncology drugs market is expected to grow from $32,769.9 million in 2021 to $56,942.6 million in 2026 at a compound annual growth rate (CAGR) of 11.7%. The market is expected to ...
Western Europe Immuno-Oncology Drugs Market Report 2022
The Western Europe immuno-oncology drugs market grew from $6,641.9 million in 2016 to $14,331.9 million in 2021 at a compound annual growth rate (CAGR) of 16.6%. The Western Europe immuno-oncology drugs market is expected to grow from $14,331.9 million in 2021 to $24,148.8 million in 2026 at a compound annual growth rate (CAGR) of 11.0%. The market is expected to ...
Eastern Euorpe Immuno-Oncology Drugs Market Report 2022
The Eastern Europe immuno-oncology drugs market grew from $629.9 million in 2016 to $1,433.3 million in 2021 at a compound annual growth rate (CAGR) of 17.9%. The Eastern Europe immuno-oncology drugs market is expected to grow from $1,433.3 million in 2021 to $2,548.7 million in 2026 at a compound annual growth rate (CAGR) of 12.2%. The market is expected to ...
South America Immuno-Oncology Drugs Market Report 2022
The South America immuno-oncology drugs market grew from $1,144.7 million in 2016 to $2,526.8 million in 2021 at a compound annual growth rate (CAGR) of 17.2%. The South America immuno-oncology drugs market is expected to grow from $2,526.8 million in 2021 to $4,608.1 million in 2026 at a compound annual growth rate (CAGR) of 12.8%. The market is expected to ...
Africa Immuno-Oncology Drugs Market Report 2022
The Africa immuno-oncology drugs market grew from $298.3 million in 2016 to $776.5 million in 2021 at a compound annual growth rate (CAGR) of 21.1%. The Africa immuno-oncology drugs market is expected to grow from $776.5 million in 2021 to $1,399.9 million in 2026 at a compound annual growth rate (CAGR) of 12.5%. The market is expected to grow to ...
Middle East Immuno-Oncology Drugs Market Report 2022
The Middle East immuno-oncology drugs market grew from $477.2 million in 2016 to $1,264.1 million in 2021 at a compound annual growth rate (CAGR) of 21.5%. The Middle East immuno-oncology drugs market is expected to grow from $1,264.1 million in 2021 to $2,434.2 million in 2026 at a compound annual growth rate (CAGR) of 14.0%. The market is expected to ...
China Immuno-Oncology Drugs Market Report 2022
The China immuno-oncology drugs market grew from $2,532.0 million in 2016 to $6,155.2 million in 2021 at a compound annual growth rate (CAGR) of 19.4%. The China immuno-oncology drugs market is expected to grow from $6,155.2 million in 2021 to $8,880.0 million in 2026 at a compound annual growth rate (CAGR) of 7.6%. The market is expected to grow to ...
India Immuno-Oncology Drugs Market Report 2022
The India immuno-oncology drugs market grew from $224.2 million in 2016 to $642.3 million in 2021 at a compound annual growth rate (CAGR) of 23.4%. The India immuno-oncology drugs market is expected to grow from $642.3 million in 2021 to $1,459.3 million in 2026 at a compound annual growth rate (CAGR) of 17.8%. The market is expected to grow to ...
Japan Immuno-Oncology Drugs Market Report 2022
The Japan immuno-oncology drugs market grew from $2,346.4 million in 2016 to $4,617.5 million in 2021 at a compound annual growth rate (CAGR) of 14.5%. The Japan immuno-oncology drugs market is expected to grow from $4,617.5 million in 2021 to $7,912.3 million in 2026 at a compound annual growth rate (CAGR) of 11.4%. The market is expected to grow to ...
Australia Immuno-Oncology Drugs Market Report 2022
The Australia immuno-oncology drugs market grew from $463.6 million in 2016 to $984.1 million in 2021 at a compound annual growth rate (CAGR) of 16.2%. The Australia immuno-oncology drugs market is expected to grow from $984.1 million in 2021 to $1,775.6 million in 2026 at a compound annual growth rate (CAGR) of 12.5%. The market is expected to grow to ...
Indonesia Immuno-Oncology Drugs Market Report 2022
The Indonesia immuno-oncology drugs market grew from $79.8 million in 2016 to $193.3 million in 2021 at a compound annual growth rate (CAGR) of 19.4%. The Indonesia immuno-oncology drugs market is expected to grow from $193.3 million in 2021 to $369.4 million in 2026 at a compound annual growth rate (CAGR) of 13.8%. The market is expected to grow to ...
South Korea Immuno-Oncology Drugs Market Report 2022
The South Korea immuno-oncology drugs market grew from $380.9 million in 2016 to $846.1 million in 2021 at a compound annual growth rate (CAGR) of 17.3%. The South Korea immuno-oncology drugs market is expected to grow from $846.1 million in 2021 to $1,564.0 million in 2026 at a compound annual growth rate (CAGR) of 13.1%. The market is expected to ...
UK Immuno-Oncology Drugs Market Report 2022
The UK immuno-oncology drugs market grew from $1,002.1 million in 2016 to $2,310 million in 2021 at a compound annual growth rate (CAGR) of 18.2%. The UK immuno-oncology drugs market is expected to grow from $2,310 million in 2021 to $4,193.1 million in 2026 at a compound annual growth rate (CAGR) of 12.7%. The market is expected to grow to ...
Germany Immuno-Oncology Drugs Market Report 2022
The Germany immuno-oncology drugs market grew from $1,556.5 million in 2016 to $3,298.9 million in 2021 at a compound annual growth rate (CAGR) of 16.2%. The Germany immuno-oncology drugs market is expected to grow from $3,298.9 million in 2021 to $5,429.6 million in 2026 at a compound annual growth rate (CAGR) of 10.5%. The market is expected to grow to ...
France Immuno-Oncology Drugs Market Report 2022
The France immuno-oncology drugs market grew from $1,168.9 million in 2016 to $2,453 million in 2021 at a compound annual growth rate (CAGR) of 16.0%. The France immuno-oncology drugs market is expected to grow from $2,453 million in 2021 to $4,047.8 million in 2026 at a compound annual growth rate (CAGR) of 10.5%. The market is expected to grow to ...
Russia Immuno-Oncology Drugs Market Report 2022
The Russia immuno-oncology drugs market grew from $264.9 million in 2016 to $590.6 million in 2021 at a compound annual growth rate (CAGR) of 17.4%. The Russia immuno-oncology drugs market is expected to grow from $590.6 million in 2021 to $1,184.6 million in 2026 at a compound annual growth rate (CAGR) of 14.9%. The market is expected to grow to ...
Brazil Immuno-Oncology Drugs Market Report 2022
The Brazil immuno-oncology drugs market grew from $685.8 million in 2016 to $1,440.0 million in 2021 at a compound annual growth rate (CAGR) of 16.0%. The Brazil immuno-oncology drugs market is expected to grow from $1,440.0 million in 2021 to $2,892.2 million in 2026 at a compound annual growth rate (CAGR) of 15.0%. The market is expected to grow to ...